Shamrock Asset Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Shamrock Asset Management’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$0	Hold	63	–	–	﹤0.01%	272
2019 Q2	$0	Hold	63	–	–	﹤0.01%	270
2019 Q1	$0	Hold	63	–	–	﹤0.01%	264
2018 Q4	$0	Hold	63	–	–	﹤0.01%	269
2018 Q3	$0	Hold	63	–	–	﹤0.01%	296
2018 Q2	$0	Hold	63	–	–	﹤0.01%	312
2018 Q1	$0	Hold	63	–	–	﹤0.01%	318
2017 Q4	$1K	Hold	63	–	–	﹤0.01%	278
2017 Q3	$1K	Sell	63 -62	-50%	-$2.35K	﹤0.01%	269
2017 Q2	$5K	Hold	125	–	–	﹤0.01%	261
2017 Q1	$6K	Hold	125	–	–	﹤0.01%	245
2016 Q4	$4K	Hold	125	–	–	﹤0.01%	243
2016 Q3	$5K	Buy	125 +62	+98%	+$2.43K	﹤0.01%	238
2016 Q2	$2K	Buy	+63	New	+$2.31K	﹤0.01%	252

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Shamrock Asset Management's GNCA Position: Q3 2019 in Review

Shamrock Asset Management held its Genocea Biosciences, Inc. (GNCA) position steady in Q3 2019 at 63 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #272.

Shamrock Asset Management first reported a position in GNCA in Q2 2016 and has held it in 14 quarters since. The position peaked at $6K in Q1 2017. 37 funds tracked by Wall St. Rank hold GNCA as of Q3 2019.

Shamrock Asset Management held 63 shares of Genocea Biosciences, Inc. worth $0 as of Q3 2019.
Shamrock Asset Management left its Genocea Biosciences, Inc. share count unchanged in Q3 2019.
Genocea Biosciences, Inc. made up ﹤0.01% of Shamrock Asset Management's portfolio in Q3 2019, its #272 holding.
Shamrock Asset Management first reported a position in Genocea Biosciences, Inc. in Q2 2016 and has held it in 14 quarters since.
Shamrock Asset Management's Genocea Biosciences, Inc. position peaked at $6K in Q1 2017.
37 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q3 2019.

Based on Shamrock Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.